-
Argus Still Bullish On Gentherm, Lowers Estimates And Price Target
Tuesday, June 14, 2016 - 1:27pm | 242Read More...Argus analyst David Coleman remained bullish on Gentherm Inc (NASDAQ: THRM) with a Buy rating. However, the analyst lowered his estimations and the price target to $44. In a note to clients, Coleman wrote, "We expect Gentherm to post solid sales and earnings this year, as more automotive...
-
Argus On LinkedIn Following Microsoft Buyout News: Acceleration Likely Under Microsoft
Tuesday, June 14, 2016 - 10:22am | 198Read More...Argus' Joseph Bonner downgraded LinkedIn Corp (NYSE: LNKD) to hold after Microsoft Corporation (NASDAQ: MSFT) announced Monday it had agreed to acquire LinkedIn for $196.00 per share. Argus downgraded the company after the share price reached past the analyst's former target price of $190.00....
-
Tesla Shares Still Have 'Significant' Upside; Argus Reiterates $333 Price Target
Tuesday, May 31, 2016 - 3:26pm | 360Read More...Argus sees significant further upside in the shares of Tesla Motors Inc (NASDAQ: TSLA) given the "outlook for improved operational and financial performance, including rapidly accelerating earnings in 2017." "Although Tesla has faced production shortfalls and cost overruns over...
-
Argus Upgrades Zimmer Biomet To Buy
Wednesday, May 25, 2016 - 8:35am | 296Read More...Following the upbeat 2016 guidance issued by Zimmer Biomet Holdings Inc (NYSE: ZBH), Argus’ David Toung believes the company has been able to overcome integration issued associated with the merger with Biomet, while the combined sales force has stabilized. Toung upgraded the rating on the...
-
Argus Reaffirms Anadarko On Focus List, Highlights 'Accelerating Cost Cuts'
Tuesday, May 24, 2016 - 9:37am | 465Read More...Argus has reaffirmed its Buy rating on Anadarko Petroleum Corporation (NYSE: APC) on recent recovery in crude oil prices and accelerating cost cuts. Analyst Justification Anadarko, which is on Argus' "Focus List," gets major share of earnings from its U.S. onshore business — Wattenberg and...
-
Argus Downgrades United Therapeutics To Hold, Cites 'Challenging Outlook'
Tuesday, May 24, 2016 - 8:08am | 296Read More...United Therapeutics Corporation (NASDAQ: UTHR) reported its 1Q16 revenue and EPS short of consensus expectations. Argus’ Jacob Kilstein downgraded the rating for the company from Buy to Hold citing the challenging outlook. United Therapeutics reported its 1Q16 revenue at $369 million, up...
-
Argus Downgrades Noble Corp, Sees Weak Outlook Ahead
Saturday, May 21, 2016 - 4:29pm | 373Read More...Argus analyst David Coleman downgraded Noble Corporation Ordinary Shares (UK) (NYSE: NE) shares to a Hold Rating from Buy, citing a weak outlook. The analyst believes that while the company should continue to gain from its fleet of high-spec rigs, he sees a further drop in offshore drilling...
-
Argus Is Still Waiting For A Better Entry Point In Norfolk
Friday, May 20, 2016 - 4:25pm | 353Read More...Argus analysts John Eade and Katelyn Bayone are still waiting for an entry point in Norfolk Southern Corp. (NYSE: NSC) shares. The analysts have retained a Hold on shares. The brokerage cited that business trends have turned negative for the rail industry, and as a high-cost operator, Norfolk...
-
Argus Reiterates Buy On Salesforce Following Strong Earnings
Friday, May 20, 2016 - 4:07pm | 345Read More...Argus analyst Joseph Bonner reiterated Buy rating on the shares of salesforce.com, inc. (NYSE: CRM). The brokerage also maintained its price target of $95. The move comes after the company delivered strong financial numbers for the first quarter. The analysts pointed out that salesforce is...
-
Argus Upgrades Exxon Mobil To Buy
Wednesday, May 18, 2016 - 10:16am | 274Read More...Argus’ Bill Selesky believes Exxon Mobil Corporation (NYSE: XOM) is “favorably valued relative to peers and continues to benefit from its diverse asset base and strong cost controls.” Selesky upgraded the rating on the company from Hold to Buy, with a price target of $104. The...
-
Argus Reiterates Focus-List Buy On Celgene Following Q1 Results
Wednesday, May 18, 2016 - 9:24am | 267Read More...Celgene Corporation (NASDAQ: CELG) reported robust 1Q results. Argus’ David Toung maintained a Focus-List Buy rating for the company, with a price target of $155. The analyst expressed optimism regarding Celgene’s long-term prospects, especially given its robust new product pipeline...
-
Home Depot Target Raised To $150, Argus Highlights 'Standout Sales'
Wednesday, May 18, 2016 - 8:46am | 281Read More...Home Depot Inc (NYSE: HD) reported a 1Q16 EPS beat, with strong sales growth. Argus’ Chris Graja maintained a Buy rating for the company, while raising the price target from $145 to $150. The analyst highlighted that the new price target reflected a total potential return of more than 15...
-
Argus: First Solar Is The Best-Positioned Company In Solar
Wednesday, May 18, 2016 - 8:34am | 342Read More...First Solar, Inc. (NASDAQ: FSLR) reported a revenue decline for 1Q16, but raised the EPS guidance for 2016. Argus' David Coleman maintained a Buy rating for the company, while slashing the price target from $90 to $66. The analyst expects First Solar’s results to be volatile on a q/q...
-
Argus Keeps Hold On MGM Resorts Due To Continued Macau Weakness
Thursday, May 12, 2016 - 10:32am | 255Read More...MGM Resorts International (NYSE: MGM) reported mixed results for 1Q. Argus’ John Staszak maintained a Hold rating for the company. The analyst commented that although MGM Resorts has a relatively greater presence in Las Vegas, its earnings are likely to be impacted by continued weakness in...
-
Disney Investors Should Be Encouraged By Shanghai Disneyland, Media Networks
Thursday, May 12, 2016 - 10:12am | 306Read More...Walt Disney Co (NYSE: DIS) reported margin expansion for the March quarter. Argus’ Joseph Bonner maintained a Buy rating for the company, with a price target of $129. The analyst commented that investments in Shanghai Disneyland were positioning the company for long-term growth, while Media...
